Displaying 1 - 7 of 7 for Cancer - Stem Cell Transplant
  • Blood Cell Disorders Study (H-35101)
    • This study will evaluate pediatric patients with malignant or non-malignant blood cell disorders who are having a blood stem cell transplant depleted of T cell receptor (TCR) alfa and beta cells that comes from a partially matched family donor.
  • CARPASCIO Study (H-33133)
    • The purpose of this study is to see whether this therapy might help people with lymphoma or leukemia after a stem cell transplantation from a donor.
  • CHARMS Study (H-33903)
    • Investigators want to see if they can use banked multivirus-specific T cells to treat infections of these viruses after a transplant: Epstein Barr virus (EBV), cytomegalovirus (CMV), BK virus, JC virus, adenovirus or HHV6 (Human Herpes Virus 6).
  • MOHEL Study (H-8701)
    • Subjects are being asked to participate in this study because treatment of their disease requires them to receive a stem cell transplant.
  • Multiple Myeloma Study (H-33837
    • The purpose of this study is to explore a drug combination alone or when combined with autologous stem cell transplantation to see what side effects it may have and how well it works for treatment of newly diagnosed multiple myeloma.
  • Viralym-A Study (H-35136)
    • In this study, investigators want to find out if the banked AdV-specific T cells derived from healthy donors are safe and can help to treat adenoviral infection.
  • Viralym-C Study (H-35887)
    • In this study, investigators want to find out if the banked CMV-specific T cells derived from healthy donors are safe and can help to treat CMV infection.